Luiz Martins Collaço

6PUBLICATIONS
29CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 16, 2022
When is There no Benefit in Performing a Biopsy in the Suspicion of Intraepithelial Lesions of the Cervix?

Marília Porto Bonow, Luiz Martins Collaço, Ana Paula Percicote

|Apr 20, 2022
Wnt3a but not CDX-2 expression is associated with differentiated thyroid cancer.

Gleyne Lopes Kujew Biagini, Carmem Austrália Paredes Marcondes Ribas, Henrique Diez Higashi

|Feb 25, 2022
Colposcopic Findings and Diagnosis in Low-Income Brazilian Women with ASC-H pap Smear Results.

Cibele Feroldi Maffini, Luiz Martins Collaço, Ana Paula Martins Sebastião

|Jan 12, 2022
DOES AGE INFLUENCE IN ENDOSCOPIC THERAPEUTIC SUCCESS ON THE BILIARY TRACT?

Luciano Hybner, Fernando Issamu Tabushi, Luis Martins Collaço

|Jan 12, 2022
COMPARATIVE ANALYSIS OF TISSULAR RESPONSE AFTER ABDOMINAL WALL REPAIR USING POLYPROPYLENE MESH AND BOVINE PERICARDIUM MESH.

Marina Bakri, Fernanda Christo Lovato, Géssica de Mattos Diosti

|Dec 17, 2020
ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN PATIENTS WITH COLORECTAL CANCER?

Fabiola Pabst Bremer, Nicolau Gregori Czeczko, Luiz Martins CollaÇo

Pageof 1